Kymera Therapeutics KYMR Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's deferred tax assets and other non-current assets?
- Kymera Therapeutics (KYMR) reported deferred tax assets and other non-current assets of $7.7M in Q1 2026.
- How has Kymera Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- Kymera Therapeutics's deferred tax assets and other non-current assets increased by 132.3% year-over-year, from $3.31M to $7.7M.
- What is the long-term trend for Kymera Therapeutics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Kymera Therapeutics's deferred tax assets and other non-current assets has grown at a 213.7% compound annual growth rate (CAGR), from $30K to $9.11M.